Sernova Corp. (TSE:SVA – Get Free Report)’s share price reached a new 52-week low during trading on Tuesday . The stock traded as low as C$0.13 and last traded at C$0.14, with a volume of 20880 shares changing hands. The stock had previously closed at C$0.13.
Sernova Price Performance
The firm has a market capitalization of C$42.73 million, a PE ratio of -2.60 and a beta of 0.73. The stock has a 50-day simple moving average of C$0.15 and a 200-day simple moving average of C$0.17. The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40.
About Sernova
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.
Further Reading
- Five stocks we like better than Sernova
- Do not delete, read immediately
- Can Any Expenses Be Deducted From Capital Gains Tax?
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
